Lonza has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp site. This multi-product facility was recently granted a GMP license after a successful audit by Swissmedic, allowing cGMP manufacturing and release of biologics produced using microbial fermentation.    The facility provides mid-scale commercial manufacturing capacity and houses two 4,000L fermenters, offering commercial manufacturing capacity that can scale to meet customer needs. The proces...